2022 Southeastern Section of the AUA extramural venous invasion as a novel MRI biomarker for adverse pathology in bladder cancer, Extramural venous invasion identified biomarker for adverse pathology studied in bladder cancer, the feasibility of identifying extramural venous invasion in patients with bladder cancer and its utility in detecting adverse pathology.
Alicia Morgans and Nima Sharifi discuss the role of the HSD3B1 gene and its variants in prostate cancer. Dr. Sharifi explains that the adrenal permissive…
APCCC 2024 treatment for biochemical recurrence/PSA persistence, stereotactic or whole pelvis radiotherapy for patients with biochemical recurrence, APCCC key questions.
Neal Shore and Mark Tyson discuss advances in non-muscle invasive bladder cancer treatments, particularly for BCG unresponsive patients. They delve into the approval and data…
APCCC 2024, Biochemical Relapse, Salvage Radiation Therapy, androgen deprivation therapy (ADT), biochemical recurrence after radical prostatectomy, Oncotype DX, Prolaris, ProMark, Decipher genomic classifier score, utilization…
APCCC 2024, prostate cancer, prostate cancer biochemical recurrence, Androgen Receptor Antagonist Monotherapy, EMBARK trial, enzalutamide, bicalutamide, leuprolide acetate, Gynecomastia after prostate cancer treatment, antineoplastic therapy,…
APCCC 2024 treatment for biochemical recurrence/PSA persistence, Decipher Genomic Classifier, persistent PSA after radical prostatectomy, detectable post-radical prostatectomy PSA.
Were you unable to attend APCCC 2024? Get all of the groundbreaking research, new guidelines, and the latest advances in urologic medicine you missed.
APCCC 2024, Prostate Cancer, Ten-year prostate cancer-specific survival rates, CALGB 90203 trial, androgen deprivation therapy (ADT), docetaxel, ADT plus docetaxel, PROTEUS trial, apalutamide, ADT plus…
APCCC 2024, locally advanced prostate cancer, extended pelvic lymph node dissection, radical prostatectomy, pN1 disease, ISUP grade group, PSMA-radio guided techniques.
APCCC 2024, Digital Rectal Examination (DRE), Local T-Stage, multi-parametric MRI (mpMRI), PROBASE trial, PRECISION trial, PRIMARY trial, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET),…
